Target intelligence / Profile preview

Oxidative phosphorylation system (OXPHOS) (OXPHOS)

Target
OXPHOS
Molecular classification
Enzyme, Transporter, Other
01

Overview

The oxidative phosphorylation (OXPHOS) system, often referred to as the mitochondrial energy metabolism machinery, is the primary site of cellular adenosine triphosphate (ATP) production in eukaryotic cells (StatPearls, 2023). It is composed of five multi-subunit enzyme complexes (Complexes I-V) and two mobile electron carriers (ubiquinone and cytochrome c) embedded within the inner mitochondrial membrane (UniProt, 2024). This machinery couples the transfer of electrons from nutrient-derived donors to molecular oxygen with the pumping of protons to create an electrochemical gradient used by ATP synthase to generate energy (Nature, 2021). Beyond bioenergetics, it is a critical regulator of cellular redox state, reactive oxygen species (ROS) production, and the intrinsic pathway of apoptosis (Nature Reviews Molecular Cell Biology, 2020). Dysfunctions in this system are central to the pathogenesis of primary mitochondrial diseases, neurodegenerative disorders like Parkinson's disease, and metabolic syndromes (PubMed, 2022). In oncology, many tumors exhibit a dependency on OXPHOS for survival and metastasis, leading to the development of drugs like IACS-010759 and atovaquone that target specific respiratory complexes (Nature Reviews Cancer, 2020). Furthermore, drugs like metformin are known to exert some of their metabolic effects through the inhibition of Complex I (Journal of Clinical Investigation, 2013). However, the essential role of mitochondrial respiration in vital organs such as the heart and brain presents a significant challenge for drug safety, often manifesting as lactic acidosis or systemic toxicity (Toxicological Sciences, 2019).

Other names
Mitochondrial energy metabolism machineryMitochondrial respiratory chainElectron transport chainMitochondrial respiratory chain complexesOXPHOS system
02

Mechanism of action

Inhibition of mitochondrial respiratory chain complexes (I-IV) or ATP synthase (Complex V) to disrupt ATP production, modulate redox balance, and induce metabolic stress.

03

Biological functions

ApoptosisCell deathOther
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseOther
05

Safety considerations

Lactic acidosisMitochondrial toxicityNeurotoxicityCardiotoxicityNarrow therapeutic window
06

Interacting drugs

Metformin

6 more in the full profile.

07

Biomarkers

Serum lactateLactate-to-pyruvate ratioOxygen consumption rate (OCR)Mitochondrial DNA copy number18F-BCPP-EF PET imaging

Beyond the preview

Go deeper on Oxidative phosphorylation system (OXPHOS) (OXPHOS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxidative phosphorylation system (OXPHOS) (OXPHOS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call